PROF logo

PROF
Profound Medical Corp

407
Mkt Cap
$253.27M
Volume
22,770.00
52W High
$8.95
52W Low
$3.76
PE Ratio
-5.59
PROF Fundamentals
Price
$6.86
Prev Close
$6.97
Open
$6.97
50D MA
$6.46
Beta
0.96
Avg. Volume
90,906.04
EPS (Annual)
-$1.41
P/B
4.26
Rev/Employee
$99,370.37
$182.53
Loading...
Loading...

About

Profound Medical Corp. is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the ablation of diseased tissue utilizing its platform technologies. The firm’s product, the TULSA-PRO system, combines real-time MRI, robotically driven transurethral sweeping action/thermal ultrasound, and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It is also focused on developing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. The company was founded on June 13, 2008 and is headquartered in Mississauga, Canada.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
162

Frequently Asked Questions

What is Market Cap of Profound Medical Corp?
What is the 52-week high for Profound Medical Corp?
What is the 52-week low for Profound Medical Corp?
What is Profound Medical Corp stock price today?
What was Profound Medical Corp stock price yesterday?
What is the PE ratio of Profound Medical Corp?
What is the Price-to-Book ratio of Profound Medical Corp?
What is the 50-day moving average of Profound Medical Corp?
How many employees does Profound Medical Corp have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available